JP2024543085A - 卵巣がんの検出のための組成物および方法 - Google Patents

卵巣がんの検出のための組成物および方法 Download PDF

Info

Publication number
JP2024543085A
JP2024543085A JP2024529398A JP2024529398A JP2024543085A JP 2024543085 A JP2024543085 A JP 2024543085A JP 2024529398 A JP2024529398 A JP 2024529398A JP 2024529398 A JP2024529398 A JP 2024529398A JP 2024543085 A JP2024543085 A JP 2024543085A
Authority
JP
Japan
Prior art keywords
biomarker
target
polypeptide encoded
human gene
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024529398A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024543085A5 (enExample
Inventor
ジョゼフ チャールズ セドラック，
ローラ テレサ ボートリン，
ダニエル パーカー セイラム，
エミリー スーザン ウィン－ディーン，
ダニエル グーセンライトナー，
ケリー ビエット，
エリック ケー． ファン，
アンソニー デイビッド クービロン，
Original Assignee
マーシー バイオアナリティクス， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マーシー バイオアナリティクス， インコーポレイテッド filed Critical マーシー バイオアナリティクス， インコーポレイテッド
Publication of JP2024543085A publication Critical patent/JP2024543085A/ja
Publication of JP2024543085A5 publication Critical patent/JP2024543085A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C12Q1/6855—Ligating adaptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2024529398A 2021-11-17 2022-11-17 卵巣がんの検出のための組成物および方法 Pending JP2024543085A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163280603P 2021-11-17 2021-11-17
US63/280,603 2021-11-17
US202263328250P 2022-04-06 2022-04-06
US63/328,250 2022-04-06
US202263417309P 2022-10-18 2022-10-18
US63/417,309 2022-10-18
PCT/US2022/050327 WO2023091618A1 (en) 2021-11-17 2022-11-17 Compositions and methods for detection of ovarian cancer

Publications (2)

Publication Number Publication Date
JP2024543085A true JP2024543085A (ja) 2024-11-19
JP2024543085A5 JP2024543085A5 (enExample) 2025-11-26

Family

ID=86397740

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024529398A Pending JP2024543085A (ja) 2021-11-17 2022-11-17 卵巣がんの検出のための組成物および方法

Country Status (5)

Country Link
US (1) US20250327129A1 (enExample)
EP (1) EP4433827A4 (enExample)
JP (1) JP2024543085A (enExample)
CA (1) CA3238997A1 (enExample)
WO (1) WO2023091618A1 (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140271453A1 (en) * 2013-03-14 2014-09-18 Abbott Laboratories Methods for the early detection of lung cancer
CN113748217B (zh) * 2019-03-01 2023-08-25 仁慈生物分析公司 用于靶实体检测的系统、组合物和方法
US20230243834A1 (en) * 2020-01-17 2023-08-03 Mercy Bioanalytics, Inc. Compositions and methods for detection of ovarian cancer

Also Published As

Publication number Publication date
US20250327129A1 (en) 2025-10-23
CA3238997A1 (en) 2023-05-25
WO2023091618A1 (en) 2023-05-25
EP4433827A4 (en) 2026-01-14
EP4433827A1 (en) 2024-09-25

Similar Documents

Publication Publication Date Title
EP3931351B1 (en) Method for target entity detection using ligase
US20230243834A1 (en) Compositions and methods for detection of ovarian cancer
CA3227133A1 (en) Compositions and methods for cancer detection
KR20230044429A (ko) 폐암의 검출을 위한 조성물 및 방법
WO2023004083A2 (en) Compositions and methods for detection of bile duct cancer
WO2023004079A2 (en) Compositions and methods for detection of liver cancer
JP2025504786A (ja) 肺がんの検出のための組成物および方法
US20240377401A1 (en) Compositions and methods for detection of prostate cancer
US20240369558A1 (en) Compositions and methods for detection of breast cancer
US20240369560A1 (en) Compositions and methods for detection of pancreatic cancer
US20240344139A1 (en) Compositions and methods for detection of colorectal cancer
US20250327129A1 (en) Compositions and methods for detection of ovarian cancer
HK40076883A (en) Compositions and methods for target protein detection on exosomes using proximal ligation
HK40066670A (en) Method for target entity detection using ligase
HK40066670B (en) Method for target entity detection using ligase

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251117

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251117